当前位置： SCI文献检索 > PEDIATRIC BLOOD & CANCER期刊下所有文献 > Protein biomarkers for incident deep venous thrombosis in critically ill adolescents: An exploratory study.

Protein biomarkers for incident deep venous thrombosis in critically ill adolescents: An exploratory study.

Abstract：

BACKGROUND:There are no tests to identify critically ill children at high risk of deep venous thrombosis (DVT). In this exploratory study, we aimed to identify proteins that are associated with incident DVT in critically ill adolescents. PROCEDURE:Plasma samples were obtained from critically ill adolescents within 24 hours after initiation of cardiopulmonary support. The adolescents were followed with ultrasound to detect the development of DVT of the lower extremity and clinically for bleeding. Thrombin-antithrombin complex and prothrombin fragment 1+2 were measured using immunosorbent assays, whereas procoagulation and anticoagulation factors were measured using multiplex assays. Plasma samples were also analyzed using SOMAscan, an aptamer-based capture assay. The associations between DVT and the log-transformed level of the proteins were assessed using logistic regression adjusting for the presence of femoral venous catheter and severity of illness. Associations were expressed as odds ratio (OR) for every log-fold increase in level of the protein with 95% confidence interval (CI). RESULTS:Plasma from 59 critically ill adolescents, of whom 9 developed incident DVT, was analyzed. The median age of the adolescents was 15.1 years (interquartile range, 14.0-16.7 years). Higher levels of thrombin-antithrombin complex (OR: 31.54; 95% CI: 2.09-475.92) and lower levels of factor XIII (OR: 0.03; 95% CI: 0.002-0.44) were associated with DVT. CD36, MIC-1, and EpoR were marginally associated with DVT. Only factor XIII was associated with clinically relevant bleeding (OR: 0.27; 95% CI: 0.08-0.97). CONCLUSIONS:We identified candidate protein biomarkers for incident DVT. We plan to validate our findings in adequately powered studies.

journal_name

Pediatr Blood Cancer

journal_title

Pediatric blood & cancer

authors

Tala JA,Polikoff LA,Pinto MG,Li S,Trakas E,Miksa M,Gertz S,Faustino EVS,THEIA Study Investigators.

doi

10.1002/pbc.28159

subject

Has Abstract

pub_date

2020-04-01 00:00:00

pages

e28159

issue

4

eissn

1545-5009

issn

1545-5017

journal_volume

67

pub_type

杂志文章,多中心研究

相关文献

PEDIATRIC BLOOD & CANCER文献大全
  • Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro.

    abstract：BACKGROUND:ABT-751, an orally bioavailable sulfonamide, binds beta-tubulin to inhibit microtubule polymerization. We described response and event-free survival (EFS) in children with neuroblastoma and other solid tumors receiving ABT-751, assessed in vitro cytotoxicity of ABT-751 and evaluated the effect of ABT-751 on ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22267

    authors： Meany HJ,Sackett DL,Maris JM,Ward Y,Krivoshik A,Cohn SL,Steinberg SM,Balis FM,Fox E

    更新日期：2010-01-01 00:00:00

  • Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools.

    abstract：BACKGROUND:The Kids ITP Tools (KIT) is a disease-specific measure of health-related quality of life for children with immune thrombocytopenia (ITP). To facilitate use in international trials it has been cross-culturally adapted for France, Germany, the United Kingdom and Uruguay. This study assessed the validity and re...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24257

    authors： Klaassen RJ,Blanchette V,Burke TA,Wakefield C,Grainger JD,Gaedicke G,Riedlinger A,Dufort G,Citrin E,Reguerre Y,Pellier I,Curtis C,Young NL

    更新日期：2013-01-01 00:00:00

  • Validation of an algorithmic nutritional approach in children undergoing chemotherapy for cancer.

    abstract：BACKGROUND:Undernutrition impacts clinical outcome adversely in children with cancer. This study aimed to validate a nutritional algorithm with specific application to the low- and middle-income country (LMIC) setting. PROCEDURE:Fifty children with a new diagnosis of cancer were enrolled in this randomized interventio...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1002/pbc.27980

    authors： Totadri S,Trehan A,Mahajan D,Viani K,Barr R,Ladas EJ

    更新日期：2019-12-01 00:00:00

  • Energy balance and its measurement in childhood disease.

    abstract：:Under and overweight, usually secondary to energy imbalance, are common complications of childhood chronic disease. A simple energy balance paradigm has been helpful in understanding the etiology of underweight and overweight in chronic disease, including malignant disease, particularly when measurements of total ener...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.21412

    authors： Reilly JJ

    更新日期：2008-02-01 00:00:00

  • A single-center experience with undifferentiated embryonal sarcoma of the liver.

    abstract：:Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26154

    authors： Mathias MD,Ambati SR,Chou AJ,Slotkin EK,Wexler LH,Meyers PA,Magnan H

    更新日期：2016-12-01 00:00:00

  • Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.

    abstract：:Immune-mediated hemolytic anemia is a well-recognized complication of hematopoietic stem cell transplantation. We report on a 6-year-old boy with X-linked adrenoleukodystrophy who developed severe delayed alloimmune hemolytic anemia associated with immune-mediated neutropenia and thrombocytopenia following major ABO i...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21187

    authors： Chao MM,Levine JE,Ferrara JL,Cooling L,Cooke KR,Hutchinson RJ,Yanik GA

    更新日期：2008-04-01 00:00:00

  • Medulloblastoma in a child with down syndrome: long-term remission with multimodality treatment.

    abstract：:A 4(3/4)-year-old male with Down syndrome (DS) presented with unsteady gait and fatigue. Neuroimaging revealed a cerebellar mass with concomitant obstructive hydrocephalus and additional metastatic lesions. He was successfully treated and is still in complete remission 5 years from diagnosis. The present case illustra...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22109

    authors： Benesch M,Moser A,Sovinz P,Lackner H,Schwinger W,Eder H,Urban C

    更新日期：2009-12-01 00:00:00

  • Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program.

    abstract：BACKGROUND:PG11047 is a novel conformationally restricted analog of the natural polyamine, spermine that lowers cellular endogenous polyamine levels and competitively inhibits natural polyamine functions leading to cancer cell growth inhibition. The activity of PG11047 was evaluated against the PPTP's in vitro and in v...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22797

    authors： Smith MA,Maris JM,Lock R,Kolb EA,Gorlick R,Keir ST,Carol H,Morton CL,Reynolds CP,Kang MH,Houghton PJ

    更新日期：2011-08-01 00:00:00

  • Healthcare Professionals' Preferences and Perceived Barriers for Routine Assessment of Patient-Reported Outcomes in Pediatric Oncology Practice: Moving Toward International Processes of Change.

    abstract：BACKGROUND:Using patient-reported outcomes (PROs) in clinical practice has been shown to enhance detection of health-related quality of life problems and satisfaction with care in children with cancer. This study seeks to identify which PRO information healthcare professionals (HCPs) find useful and what the perceived ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26135

    authors： Schepers SA,Haverman L,Zadeh S,Grootenhuis MA,Wiener L

    更新日期：2016-12-01 00:00:00

  • High birth prevalence of sickle cell disease in Northwestern Tanzania.

    abstract：BACKGROUND:Worldwide, hemoglobinopathies affect millions of children. Identification of hemoglobin disorders in most sub-Saharan African countries is delayed until clinical signs of the disease are present. Limited studies have been conducted to understand their prevalence and clinical presentation among newborns in re...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.26735

    authors： Ambrose EE,Makani J,Chami N,Masoza T,Kabyemera R,Peck RN,Kamugisha E,Manjurano A,Kayange N,Smart LR

    更新日期：2018-01-01 00:00:00

  • Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.

    abstract：BACKGROUND:Extramedullary infiltration (EMI) is an occasional clinical symptom in childhood acute myelogenous leukemia (AML), but there is considerable controversy regarding the prognostic significance of EMI in AML. PROCEDURE:We evaluated the frequency and prognostic significance of EMI at diagnosis of AML in childre...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20824

    authors： Kobayashi R,Tawa A,Hanada R,Horibe K,Tsuchida M,Tsukimoto I,Japanese childhood AML cooperative study group.

    更新日期：2007-04-01 00:00:00

  • Sickle-cell disease in California: a population-based description of emergency department utilization.

    abstract：BACKGROUND:Acute and chronic clinical manifestations of sickle-cell disease (SCD) lead to significant healthcare utilization, especially of the emergency department (ED). Limited population-level data are available in SCD with the ability to connect patients to visits, leaving us with minimal description of utilization...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.22792

    authors： Wolfson JA,Schrager SM,Coates TD,Kipke MD

    更新日期：2011-03-01 00:00:00

  • Different 18 F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors.

    abstract：BACKGROUND:The histological response to neoadjuvant chemotherapy (NAC) in pediatric patients with Ewing sarcoma family of tumors (ESFT) can predict the disease-free survival. Therefore, a noninvasive method for response assessment is needed. Using the currently established imaging modalities, mass reduction does not al...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28605

    authors： El-Hennawy G,Moustafa H,Omar W,Elkinaai N,Kamel A,Zaki I,Farid N,El-Kholy E

    更新日期：2020-11-01 00:00:00

  • Sex ratio among childhood cancers by single year of age.

    abstract：BACKGROUND:The male excess in childhood cancer incidence is well-established; however, the underlying biologic mechanisms remain unknown. Examining the association between male sex and childhood cancer by single year of age and tumor type may highlight important periods of risk such as variation in growth and hormonal ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.27620

    authors： Williams LA,Richardson M,Marcotte EL,Poynter JN,Spector LG

    更新日期：2019-06-01 00:00:00

  • Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.

    abstract：BACKGROUND:Hematopoietic stem cell transplantation (HSCT) provides a curative therapy for children severely affected by sickle cell disease (SCD). Rejection-free survival after matched sibling donor (MSD) HSCT is very high, but adoption of HSCT as a curative SCD therapy has been slow. In this study, we assess providers...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28861

    authors： Meier ER,Abraham AA,Ngwube A,Janson IA,Guilcher GMT,Horan J,Kasow KA

    更新日期：2021-03-01 00:00:00

  • Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program.

    abstract：BACKGROUND:Alvespimycin (17-DMAG, KOS-1022), a potent small-molecule inhibitor of the protein chaperone Hsp90, is being developed as an anticancer agent because of the multiple Hsp90 client proteins involved in cancer cell growth and survival. PROCEDURES:Alvespimycin was tested against the in vitro panel of the Pediat...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21508

    authors： Smith MA,Morton CL,Phelps DA,Kolb EA,Lock R,Carol H,Reynolds CP,Maris JM,Keir ST,Wu J,Houghton PJ

    更新日期：2008-07-01 00:00:00

  • Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child.

    abstract：:Malignant mesothelioma (MM) is a highly aggressive malignancy that is extremely rare in children. This case report documents a 7-year-old male without previous asbestos exposure with peritoneal MM that initially responded to chemotherapy with cisplatin and gemcitabine but ultimately metastasized to his chest. He was d...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24284

    authors： Sugalski A,Davis M,Prasannan L,Saldivar V,Hung JY,Tomlinson GE

    更新日期：2013-01-01 00:00:00

  • Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.

    abstract：:Essential thrombocythemia is a rare myleoproliferative disorder in pediatrics. This myleoproliferative disorder is characterized by excessive proliferation of megakaryocytes and sustained elevation of platelet count. Reactive thrombocytosis is a more common cause of elevated platelet counts among children. We describe...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21218

    authors： Robins EB,Niazi M

    更新日期：2008-04-01 00:00:00

  • Health-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium.

    abstract：BACKGROUND:Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickl...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.22497

    authors： Dampier C,Lieff S,LeBeau P,Rhee S,McMurray M,Rogers Z,Smith-Whitley K,Wang W,Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium (CTC).

    更新日期：2010-09-01 00:00:00

  • The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors.

    abstract：BACKGROUND:Advanced irradiation techniques, including intensity-modulated radiation therapy (IMRT), aim to limit irradiation to adjoining tissues by conforming beams to a well-defined volume. In intracranial germinomas, whole-ventricular IMRT decreases the volume of irradiation to surrounding parenchyma. This study exa...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28005

    authors： Toll SA,Jones MT,Yoshida EJ,Dhall G,Olch AJ,Wong KK

    更新日期：2019-12-01 00:00:00

  • The diagnostic dilemma of congenital unstable hemoglobinopathies.

    abstract：:Unstable hemoglobin variants represent a rare etiology of congenital hemolytic anemia. Without a high index of suspicion, plus proper laboratory testing and interpretation, the correct diagnosis can be elusive. We report on five children who were initially thought to have other congenital disorders such as hereditary ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22702

    authors： Yates AM,Mortier NA,Hyde KS,Hankins JS,Ware RE

    更新日期：2010-12-15 00:00:00

  • Chickenpox in varicella IgG positive patients: experience of a regional paediatric oncology centre.

    abstract：:Aciclovir prophylaxis was previously given to all immunocompromised patients treated by our unit, following contact with varicella zoster. In 2003, we changed practice according to National Guidelines, giving prophylaxis only to patients without serum varicella zoster immunoglobulin G antibody (VZ IgG) at diagnosis of...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21521

    authors： Manley S,Mallinson H,Caswell M,Keenan R,Pizer B

    更新日期：2008-10-01 00:00:00

  • 2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer.

    abstract：:The Standards, Options, and Recommendations (SOR) project undertaken by the French National Federation of Cancer Centers (FNCLCC) to develop and disseminate clinical practice guidelines in oncology has now been taken over by the French National Cancer Institute. In 2007, the SOR updated the information related to the ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.21953

    authors： Marec-Berard P,Chastagner P,Kassab-Chahmi D,Casadevall N,Marchal C,Misset JL,Ray-Coquard I

    更新日期：2009-07-01 00:00:00

  • Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua.

    abstract：:We report the results of a protocol for the diagnosis and treatment of pediatric non-Hodgkin lymphomas (NHL) conducted in Nicaragua in the context of an international collaborative program. Fifty-three children with NHL treated between 1996 and 2003 were retrospectively evaluated. Therapy was designed based on local d...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21046

    authors： Baez F,Pillon M,Manfredini L,Ocampo E,Mendez G,Ortiz R,Palacios R,Gutierrez T,Tridello G,Conter V,Valsecchi M,Fossati Bellani F,Cavalli F,Masera G,Rosolen A

    更新日期：2008-01-01 00:00:00

  • Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review.

    abstract：:The incidence of bone marrow metastasis (BMM) in newly diagnosed Ewing sarcoma (ES) is variable across studies. An optimal staging strategy for detecting BMM is not defined. While bone marrow (BM) biopsy and/or aspirate (BMBA) have been the gold standard, [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET)...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.28807

    authors： Campbell KM,Shulman DS,Grier HE,DuBois SG

    更新日期：2021-02-01 00:00:00

  • A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients.

    abstract：BACKGROUND:Fever and neutropenia (F&N) is a pediatric oncology emergency due to the risk of disseminated infection. Quality improvement (QI) efforts to improve time to antibiotics for F&N in the emergency department have been documented, but the issue has not been studied in the established inpatient setting. PROCEDUR...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25712

    authors： Green AL,Yi J,Bezler N,Pikman Y,Tubman VN,Obeng EA,O'Neil T,Mersereau R,Morrissey L,Billett AL

    更新日期：2016-01-01 00:00:00

  • Elevated mitochondrial DNA copy numbers in pediatric acute lymphoblastic leukemia: A potential biomarker for predicting inferior survival.

    abstract：BACKGROUND:Studies on mitochondrial DNA copy number reveal an increase or decrease in copy number that appears to be cancer specific, but data on acute lymphoblastic leukemia have been inconsistent regarding the significance of changes in mitochondrial DNA copies. The purpose of this pilot study was to analyze mitochon...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1002/pbc.26874

    authors： Jain A,Bakhshi S,Thakkar H,Gerards M,Singh A

    更新日期：2018-03-01 00:00:00

  • The burden of childhood cancer in Mexico: Implications for low- and middle-income countries.

    abstract：:In Mexico, childhood cancer incidence and mortality have increased in the last decade. Through government actions since 2005, the Popular Medical Insurance (PMI) program for childhood cancer was created. The objective of PMI was to offer early cancer diagnosis, standardized treatment regimens, and numerous pediatric o...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.26366

    authors： Rivera-Luna R,Zapata-Tarres M,Shalkow-Klincovstein J,Velasco-Hidalgo L,Olaya-Vargas A,Finkelstein-Mizrahi N,Cárdenas-Cardós R,Aguilar-Ortiz MR

    更新日期：2017-06-01 00:00:00

  • Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.

    abstract：BACKGROUND:The neurokinin-1 receptor antagonist aprepitant, plus a 5HT3 antagonist and corticosteroid is well-tolerated and effective in preventing chemotherapy-induced nausea and vomiting in adults but has not been formally assessed in adolescents. PROCEDURE:Patients age 11-19 years old receiving emetogenic chemother...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1002/pbc.21811

    authors： Gore L,Chawla S,Petrilli A,Hemenway M,Schissel D,Chua V,Carides AD,Taylor A,Devandry S,Valentine J,Evans JK,Oxenius B,Adolescent Aprepitant in Cancer Study Group.

    更新日期：2009-02-01 00:00:00

  • Efficacy and safety of administering pediatric treatment to adolescent patients with mature B-cell non-Hodgkin lymphoma within the Japanese Pediatric Leukemia/Lymphoma Study Group clinical trial.

    abstract：BACKGROUND:Currently, there is no standardized treatment for adolescents, aged 15 years or older, with mature B-cell non-Hodgkin lymphoma (B-NHL), although this age group has been reported to have a poorer prognosis than younger patients. PROCEDURE:The present study analyzed the data of 321 patients with B-NHL, enroll...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.27068

    authors： Sekimizu M,Hashimoto H,Mori T,Kobayashi R,Horibe K,Tsurusawa M

    更新日期：2018-08-01 00:00:00